期刊文献+

格列卫激活caspase-3诱导K562细胞凋亡 被引量:5

Gleevec induces apoptosis in K562 cells through activating caspase-3
原文传递
导出
摘要 本文主要探讨格列卫诱导慢性粒细胞白血病K562细胞凋亡的分子机制。采用流式细胞术检测格列卫对K562细胞凋亡和细胞周期的影响、caspase泛阻断剂Z-VAD-FMK及沉默PDCD4表达对格列卫诱导K562细胞凋亡的影响;Western blotting分析si-PDCD4对PDCD4蛋白的沉默效果,以及格列卫对caspase-3和PARP蛋白的活化及PDCD4蛋白表达的影响。结果显示,格列卫能显著诱导K562细胞发生凋亡和阻滞于G0/G1期,促进caspase-3和PARP蛋白的活化,上调PDCD4蛋白的表达;Z-VAD-FMK抑制剂显著抑制格列卫诱导的细胞凋亡(47.97%±10.56%vs 31.05%±9.206%,P<0.05);si-PDCD4能有效抑制PDCD4蛋白的表达;si-PDCD4沉默PDCD4蛋白表达能部分抑制格列卫诱导的细胞凋亡(46.97%±14.32%vs 42.8%±11.43%)。综上所述,格列卫通过激活caspase-3诱导K562细胞凋亡。 The present study is to elucidate the mechanisms underlying Gleevec-induced apoptosis of chronic myeloid leukemia (CML) K562 cells in vitro. The apoptotic cell death and cell cycle distribution after Gleevec treatment and the effect of PDCD4 siRNA on Gleevec-induced apoptosis of K562 cells were analyzed by flow cytometry. The effect of Gleevec on p-Crkl, caspase-3, PARP and PDCD4 protein levels, and the knockdown efficacy of PDCD4 siRNA were detected by Western blotting. The results showed that Gleevec dramatically suppressed the phosphorylation level of Crkl in a dose-dependent manner and induced significant apoptosis and Go/Gl cell cycle arrest of K562 cells in time- and dose-dependent manners. In addition, Gleevec activated caspase-3 and its downstream substrates PARP, and the caspase pan inhibitor Z-VAD-FMK (50 μmol·L^-1) markedly reduced Gleevec-induced apoptosis from 47.97% ± 10.56% to 31.05% ± 9.206% (P 〈 0.05). Moreover, Gleevec significantly increased the protein expression of programmed cell death 4 (PDCD4). PDCD4 knockdown by siRNA reduced Gleevec-induced apoptosis from 46.97% ± 14.32% to 42.8%±11.43%. In summary, Gleevec induced apoptosis in K562 cells via caspase-3 activation.
出处 《药学学报》 CAS CSCD 北大核心 2014年第8期1124-1129,共6页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(81100369) 广州市科技计划项目(11C22130682)
关键词 格列卫 慢性粒细胞白血病 K562细胞 细胞凋亡 CASPASE-3 Gleevec chronic myeloid leukemia K562 cell apoptosis caspase-3
  • 相关文献

参考文献2

二级参考文献30

  • 1Brauer KM, Werth D, von Schwarzenberg K, Bringmann A, Kanz L, Grunebach F, et al. BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells. Cancer Res 2007; 67: 5489-97.
  • 2Goldman JM, Melo N. Chronic myeloid leukemia - advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 1451-64.
  • 3Goldman JM, Melo N. Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1084-6.
  • 4Yoshida C, Yoshida F, Sears DE, Hart SM, Ikebe D, Muto A, et al. BcrAbl signaling through the PI-3jS6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-l. Blood 2007; 109: 1211-9.
  • 5Strout MP, Schatz DG. Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way. Cancer Cell 2009; 16: 174-6.
  • 6lu Z, Jin Y, Chen C, Li J, Cao Q, Pan J. Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T3151 mutation by blocking NF-kappaB signaling and depleting BcrAbl. Mol Cancer 2010; 9: 112.
  • 7Deguchi Y, Kimura S, Ashihara E, Niwa T, Hodohara K, Fujiyama Y, et al. Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines. Leuk Res 2008; 32: 980-3.
  • 8Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA doublestranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273: 5858-68.
  • 9Lu C, Zhu F, Cho YY, Tang F, Zykova T, Ma WY, et al. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell 2006; 23: 121-32.
  • 10Lu C, Shi Y, Wang Z, Song Z, Zhu M, Cai Q, er a/. Serum starvation induces H2AX phosphorylation to regulate apoptosls via p38 MAPK pathway. FEBS Lett 2008; 582: 2703-8.

共引文献7

同被引文献80

  • 1庄严,王丹丹,柳忠兰,王建华,曹亦宾.吸烟对大鼠局灶性脑缺血后Caspase-3表达及细胞凋亡的影响[J].中国老年学杂志,2014,34(1):156-158. 被引量:3
  • 2罗进勇,李林,尹一兵.槲皮素对人肺腺癌A549细胞增殖和凋亡的影响[J].重庆医学,2005,34(4):551-552. 被引量:10
  • 3陈洪雷,高俊,梁素美,刁路明,邹祖玉.人肺癌组织中caspase-3及其底物PARP蛋白的表达和意义[J].武汉大学学报(医学版),2005,26(6):726-729. 被引量:8
  • 4魏绍斌,要永卿,王毅,郭蓉晓,仝崇毅,谭亿民.盆炎康栓对慢性盆腔炎模型大鼠子宫内膜细胞NF-κB、Caspase-3、MMP-2表达的影响[J].中国中医药信息杂志,2006,13(3):31-33. 被引量:11
  • 5YAO Shaohua, XIE Lifang, QIAN Meilin, et al. Pnas4 is a novel regulator for convergence and extension during verte brategastrulation [J]. FEBS Lett, 2008, 582(15) 2325- 2332.
  • 6YAN Fei, RUAN Xuzhi, "fANG Hanshuo, et al. Identifica- tion, characterization, and effects of Xenopus laevis PNAS-4 gene on embryonic development [J]. J Biomed Biotechnol, 2010, 2010= Article ID 134764.
  • 7YAN Fei, GOU Lantu, YANG Jinliang, et al. A novel pro- apoptosis gene PNAS4 that induces apoptosis in A549 human lung adenocarcinoma cells and inhibits tumor growth in mice[J]. Biochimie, 2009, 91(4): 502-507.
  • 8HOU Shengyan, ZHAO Zhiwei, YAN Fei, et al. Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer [J]. Cell Biol lnt, 2009, 33(3) : 276-282.
  • 9YANG F, LI Z Y, DENG H X, et al. Efficient inhibition of ovarian cancer growth and prolonged survival hy transfection with a novel pro-apoptotie gene, hPNAS-4, in a mouse mod- el. In vivo and in vitro results [J]. Oncology, 2008, 75(3 4) : 137-I44.
  • 10YUAN Zhu, I.IU Huanyi, YAN Fei, et al. Improved thera- peutic efficacy against murine carcinoma by combining honoki ol with gene therapy of PNAS-4, a novel pro-apoptotie gene [J]. Cancer Sci, 2009, 100(9) 1757-1766.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部